Bicara Therapeutics Inc. (BCAX)

SEC filing

Bicara Therapeutics Inc.

BCAX · CIK 2023658

4 · Sep 10, 2026 · Director, President, COO & Interim CEO Cohlhepp Ryan sold 17.50K shares at $22.90/share ($400.7K); exercised options for 17.50K shares

Director, President, COO & Interim CEO Cohlhepp Ryan sold 17.50K shares at $22.90/share ($400.7K); exercised options for 17.50K shares

Filed: Sep 10, 2026
Period: Sep 8, 2026
Accession: 0001470831-26-000883
Filer: Bicara Therapeutics Inc.

View on SEC.gov All SEC filings

Filing document

FORM 4

xslF345X06/wk-form4_1789071782.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4FORM 4wk-form4_1789071782.xml
Open SEC.gov